Company Profile

PHARMAIDS PHARMACEUTICALS LTD.

NSE : NABSE : 524572ISIN CODE : INE117D01018Industry : TradingHouse : Private
BSE14.50-0.75 (-4.92 % )
PREV CLOSE (Rs.) 15.25
OPEN PRICE (Rs.) 15.75
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 24230
TODAY'S LOW / HIGH (Rs.)14.50 15.75
52 WK LOW / HIGH (Rs.) 2.73 30.4
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 3.60775
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) NA
ROCE (%) -4.45
Incorporation Year : 1989

Management Info :

- Chairman - Managing Director

Registered Office :

Address : 4-4-211/212/3,1st Floor,sultan Bazar,Inderbagh,
Hyderabad,
Telangana-500095

Phone : 040-40122151

Website : www.pharmaids.com

Registrar's Details : Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE
NEWS More
16Jul07-16-2021$ Board Meeting Intimation for Board Meeting Intimation Board Meeting Intimation fo
PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2021 ,inter alia, to consider and approve Dear Sir/Madam, Please find attached intimation for the Board Meeting scheduled on 23-07-2021 to consider the unaudited financial results for the quarter ended 30-06-2021 and other matters. Regards, For Pharmaids Pharmaceuticals Limited. S. Padmaja Kalyani Director
PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting..
15May05-15-2021$Pharmaids Pharmaceuticals informs about board meeting Pharmaids Pharmaceuticals in

Pursuant to Regulation 29 and 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company is scheduled to be held Monday, May 24, 2021 to consider the following business: Approval of audited financial results for the quarter and year ended 31.03.2021 and any Other matter with the permission of the Chair. Further, in accordance with its letter dated 31st March, 2021 the Trading window shall remain closed till 48 hours after communication of aforesaid Financial Results to the Stock Exchange.

The above information is a part of company’s filings submitted to BSE.


Pursuant to Regulation 29 and 47 of the SEBI (Listing Obligatio..
05May05-05-2021$ Clarification On Price Movement Clarification On Price Move
Dear Sir/ Madam, Please find the attached Clarification on Price Movement. Regards, Annie Jodhani Company Secretary
Dear Sir/ Madam, Please find the attached Clarification on P..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit0.1000000000000010.929999999999998
Gross Profit 0.420000000000001 0.879999999999998
Operating Profit 0.4600000000000011.33
Net Sales 23.4185.51
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Nureca Ltd. (BSE)
 1905.45 (5.00%)
M.Cap ( in Cr)
1905.48
Competent Auto (BSE)
 249.75 (12.80%)
M.Cap ( in Cr)
153.50
Ind Link Chain Mfg (BSE)
 445.70 (4.99%)
M.Cap ( in Cr)
2.23
Riddhi Siddhi Gluco (BSE)
 378.45 (4.99%)
M.Cap ( in Cr)
269.83
Cravatex (BSE)
 323.00 (3.86%)
M.Cap ( in Cr)
83.47
Shareholding Pattern More
PROMOTERS 65.8 %
NON-INSTITUTION 34.2 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes